Long Term Care Journal
Friday, May 24, 2019
FDA approves first PI3K inhibitor for breast cancer - FDA Press Releases
FDA approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine therapy fulvestrant.
from FDA Press Releases RSS Feed http://bit.ly/2W2QsKA
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment